Posts in tag

deprescribing


Debbie Rigby rounds up the latest in research news Risk of Fracture and Osteoporosis in Patients with COPD and Inhaled Corticosteroids Treatment This meta-analysis of 26 RCTs (n=61,380) concluded that …

The profession’s focus shifts back to Canberra, with plans for another protest against 60-day dispensing moving ahead, plus the announcement of a review into full scope The planned rally for …

If a patient is making jokes about taking so many medicines they “rattle”…could they be open to deprescribing? Many older people are less resistant to deprescribing than a lot of …

Australia’s healthcare system needs to be reformed to better support deprescribing, expert says  Efforts to improve quality use of medicines in Australia are being limited by the current health system, …

Hospital pharmacists are looking to empower patients and their carers to engage with health professionals to optimise their medication regimens  The Society of Hospital Pharmacists of Australia (SHPA) in partnership with …

Debbie Rigby takes a look at the latest in research news Menopausal hormone therapy and dementia A case control study conducted with more than 60,000 women aged 50 to 60 …

Debbie Rigby takes a look at the latest in research news Clinical practice guideline for deprescribing opioid analgesics This paper is a summary of the Evidence‐based clinical practice guideline for …

New opioid deprescribing guidelines have been published by researchers led by a hospital pharmacist In her work in the hospital sector, early career pharmacist Dr Aili Langford has already seen …

Debbie Rigby takes a look at the latest in research news Aspirin deprescribing in primary prevention of cardiovascular disease Current evidence and practice guidelines do not recommend aspirin for primary …

Debbie Rigby rounds up the latest in research news Clinical Practice Guidelines for Cannabis and Cannabinoid-Based Medicines in the Management of Chronic Pain and Co-Occurring Conditions These clinical practice guidelines …

Frailty substantially increases the risk of older persons experiencing medication-related harm. People approaching frailty or living with mild frailty should be targeted for medication reviews, regardless of the number of …

This article provides a practical approach to identifying drugs that increase the anticholinergic burden and recognise risks and adverse effects. Suggestion will be offered to assist with decisions about providing …